Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection

MLA

Diógenes Santiago Santos, et al. “Mefloquine and Its Oxazolidine Derivative Compound Are Active against Drug-Resistant Mycobacterium Tuberculosis Strains and in a Murine Model of Tuberculosis Infection.” International Journal of Antimicrobial Agents, vol. 48, Aug. 2016, pp. 203–07. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2016.04.029.

APA

Diógenes Santiago Santos, Julian Gonzalez-Martin, Rogério Valim Trindade, Alexandre López-Gavín, Raoni Schroeder B. Gonçalves, Valnês S. Rodrigues-Junior, Bruno Lopes Abbadi, Marcus V. N. de Souza, Anne Drumond Villela, Maria M. Campos, Luiz Augusto Basso, & Griselda Tudó. (2016). Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection. International Journal of Antimicrobial Agents, 48, 203–207. https://doi.org/10.1016/j.ijantimicag.2016.04.029

Chicago

Diógenes Santiago Santos, Julian Gonzalez-Martin, Rogério Valim Trindade, Alexandre López-Gavín, Raoni Schroeder B. Gonçalves, Valnês S. Rodrigues-Junior, Bruno Lopes Abbadi, et al. 2016. “Mefloquine and Its Oxazolidine Derivative Compound Are Active against Drug-Resistant Mycobacterium Tuberculosis Strains and in a Murine Model of Tuberculosis Infection.” International Journal of Antimicrobial Agents 48 (August): 203–7. doi:10.1016/j.ijantimicag.2016.04.029.